Interscalene Block Versus Erector Spinae Plane Block for Shoulder Arthroscopy Anesthesia
1 other identifier
interventional
54
1 country
1
Brief Summary
The aim of this study is to compare the effectiveness of ESPB versus ISB in anesthesia for shoulder arthroscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2022
CompletedFirst Posted
Study publicly available on registry
December 12, 2022
CompletedStudy Start
First participant enrolled
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedApril 19, 2023
April 1, 2023
5 months
December 4, 2022
April 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Intraoperative fentanyl consumption
Fntanyl will be administered 1 µg/kg IV increments.
30 minutes
Secondary Outcomes (3)
Postoperative pain
24 hours postoperative
Rescue analgesia in the form of IV meperidine (0.5 mg/kg) boluses if NRS >3. Time to the 1st rescue analgesic request will be recorded
24 hours postoperative
Total amount of rescue analgesic
24 hours postoperative
Study Arms (2)
Erector spinae plane block group
ACTIVE COMPARATOR3ml lidocaine 2% will be used to anesthetize the skin. Using a 20-gauge block needle put in-plane in a cephalad-to-caudad orientation to position the tip into the fascial plane on the deep (anterior) side of the erector spinae muscle, 20 ml bupivacaine 0.5% will be injected.
Interscalene group
ACTIVE COMPARATORUsing a lateral-to-medial approach, the 25-gauge needle will be inserted into the middle scalene muscle, advanced, and placed immediately lateral to the nerve roots. the needle will be visualize using an ultrasound beam to avoid intraneural and intravascular injections. After confirming negative blood aspiration, we will inject 15 mL of 0.5% bupivacaine around the nerve roots
Interventions
Using a 20-gauge block needle put in-plane in a cephalad-to-caudad orientation to position the tip into the fascial plane on the deep (anterior) side of the erector spinae muscle, 20 ml bupivacaine 0.5% will be injected
Using a lateral-to-medial approach, the 25-gauge needle will be inserted into the middle scalene muscle, advanced, and placed immediately lateral to the nerve roots. the needle will be visualize using an ultrasound beam to avoid intraneural and intravascular injections. After confirming negative blood aspiration, we will inject 15 mL of 0.5% bupivacaine around the nerve roots
Eligibility Criteria
You may qualify if:
- Patients with Body Mass Index \< 40 kg/m2
- American Society of Anesthesiologists (ASA) physical status I-II
- scheduled for elective shoulder arthroscopy
You may not qualify if:
- Known allergy to local anesthetics
- Allergy to all opioid medications
- Diagnostic shoulder arthroscopic procedures
- Patients with chronic opioids
- Patients who converted to general anesthesia use and coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Islam Morsy
Tanta, El-Gharbia, 31527, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesia, Surgical Intensive Care and Pain Medicine
Study Record Dates
First Submitted
December 4, 2022
First Posted
December 12, 2022
Study Start
December 15, 2022
Primary Completion
May 15, 2023
Study Completion
May 15, 2023
Last Updated
April 19, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- For one year after completion of the study
The data will be available upon reasonable request from the principal investigator